Pharmac Message on Mesalazine Tablets
Posted Wednesday September 3, 2025
From 1 July 2025 Pharmac listed Mesalazine 1600mg tablets, Asacol brand.
Due to the current shortage of mesalazine 400mg tablets please consider prescribing mesalazine 1600mg for patients that are taking a 1600mg dose.
This is a Section 29 (unapproved) medicine.
Additional information can be found here - Mesalazine tablets Pharmac website
Gallery
Related Articles
Introduction to Endoscopy - August 2025
Sunday September 7, 2025
NZSG thanks everyone who made the 2025 Introduction to Endoscopy Course successful
JSGE Research Fellowship Program Award 2026
Sunday September 7, 2025
The NZSG Executive is looking to nominate a member to this program - is it you?
Hepatology Network Meeting - Take 2
Sunday September 7, 2025
The second instalment of the Hepatology Network Meeting for 2025 was held recently in Christchurch